ML-Ranked Picks
Subscribers get a focused list of Phase 3 programs we believe are worth tracking most closely.
Free Subscriber Launch
AI-Driven Machine Learning Predictions, on Phase 3 Clinical Trial Outcomes
BioLensTracker analyzes Phase 2 trial abstracts to score Phase 3 setups, publishes focused email rounds with simple reasoning, and offers optional SMS clinical trial alerts when topline results are released.
Subscriber Value
What Free Subscribers Get During Launch
Phase 1 gives early subscribers email access to our picks and reasoning, plus optional SMS clinical trial alerts when outcomes are confirmed.
Evidence Included
Each pick is paired with clear reasoning rooted in Phase 2 abstract evidence.
Email Rounds + Trial Alerts
Subscribers get email when a new round goes live and can optionally receive SMS when Phase 3 outcomes are confirmed.
How It Works
A Simple Picks and Updates Workflow
A repeatable loop that turns Phase 2 evidence into a focused email round of picks, then tracks results to the finish.
- 1We review upcoming Phase 3 drug trial events on a regular cycle.
- 2We score Phase 3 setups using Phase 2 abstract signals and a machine-learning model.
- 3We publish a new email round with the active picks and the reasoning behind them.
- 4We monitor outcomes and notify subscribers by email and optional SMS when results are confirmed.
What Subscribers Are Following
BioLensTracker helps subscribers follow which programs we are tracking into Phase 3, why they made the list, and what happens when topline data is released through email updates and optional SMS trial alerts.
Completed Picks
Preview Completed Picks
Tiles show sponsor price movement from three trading days before topline events through three trading days after.
Abivax S.A.
ABVX
Topline: July 22, 2025
+543.0% from 3 days before to 3 days after
Alumis Inc.
ALMS
Topline: January 6, 2026
+100.4% from 3 days before to 3 days after
Xenon Pharmaceuticals
XENE
Topline: March 9, 2026
+34.5% from 3 days before to 3 days after
DBV Technologies
DBVT
Topline: December 17, 2025
+10.3% from 3 days before to 3 days after